Skip to main content
. 2023 Dec 17;11(12):3334. doi: 10.3390/biomedicines11123334

Figure 1.

Figure 1

Improvement in motor function following single-dose transplantation with NRPCs using the gait test and NCS. Image of footprint (A) and graph of SFI (B) to confirm motor function recovery in gate test at 4, 8, and 12 weeks after transplantation. Representative graph of NCS (C) and CMAP and NCV measurements (D) 12 weeks after transplantation. Statistical analysis with one-way ANOVA was performed for comparison between groups, and data are presented as mean ± SEM (* p < 0.05; ** p < 0.01; *** p < 0.001). NRPCs, neuronal regeneration-promoting cells; NCS, nerve conduction study; SFI, sciatic functional index; CMAP, compound muscle action potential; NCV, nerve conduction velocity; NRPC-L, NRPC-low; NRPC-M, NRPC-medium; NRPC-H, NRPC-high; W/T, wild-type.